2015
20th Congress of EHA, Vienna, Austria
Application of Systems Pharmacology Modeling for Evaluation of Therapies Effect on Blast Dynamics in Acute Lymphoblastic Leukemia
Authors: Antonina Nikitich, Oleg Demin Jr
2014
Systems Pharmacology in Drug Discovery & Development, Noordwijkerhout, The Netherlands
A systems pharmacology model of purine metabolism to explore novel options for the treatment of Gout
Authors: Pinky Dua, Oleg Demin Jr, Viktor Sokolov, Tatiana Yakovleva, Oleg Demin, Piet van der Graaf
Affiliation: Clinical Pharmacology, Pfizer Neusentis, Cambridge UK; InSysBio, Moscow, Russia; Leiden Academic Centre for Drug Research (LACDR), The Netherland
ASCPT 2014, Atlanta, GE, US
Systems Pharmacology Modeling of Calcium and Phosphate Metabolism in Chronic Kidney Disease
Authors: Antonina Bakhmutova, Oleg Demin Jr, Oleg Demin
Development and Application of Systems Pharmacology Model to Predict Nausea Resulted from Administration GLP-1 Agonists
Authors: Veronika Voronova, Oleg Demin Jr, Sergei Smirnov, Oleg Demin
EMBL-EBI Industry Systems Pharmacology Workshop, Cambridge, UK
Systems pharmacology modeling in drug research and development: application of modeling technique
Speaker: Oleg Demin
2013
ACoP4, Fort Lauderdale, FL, US
Development of a Human System Pharmacology Model to Characterize Diabetic Nephropathy Disease Progression and the Effect of Standard of Care Therapy.
Authors: Danny Chen, Veronika Voronova, Sergey Smirnov, Evgeny Metelkin, Ekaterina Goryacheva, Antonina Bahmutova, Oleg Demin
Affiliation: Pfizer Inc. Cambridge, MA; InSysBio, Moscow, Russia
ASCPT 2013, Indianapolis, IN, US
Systems Pharmacology Modeling in Research and Development
Speaker: Oleg Demin
Exploration of molecular mechanisms underlying susceptibility of HCV patients to IFN-? therapy via systems pharmacology modeling
Authors: Oleg Demin, Sergey Smirnov, Neil Benson, Piet H. van der Graaf, Victoria Flores, Ekaterina Goryacheva, Oleg Demin
Affiliation: InSysBio, Moscow, Russia; Pfizer, Sandwich, UK
First
Prev